Concepedia

Author

Mo Xiao

Nanjing Medical University

Also Known As

Mo Xiao, Xiao Mo

13

Publications

459

Citations

10

H-Index

32

Concepts

All Affiliations

Nanjing Medical UniversityJiangsu Cancer HospitalWannan Medical CollegeShandong UniversityFirst Affiliated Hospital of Wannan Medical College
MX

About

Mo Xiao is an author at Nanjing Medical University specializing in medicine, cell biology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

239

2

Cell Biology

4

4

130

3

Health Sciences

2

2

125

4

Hepatology

2

2

125

5

Biochemistry

1

1

109

Mo Xiao

×

8

Publications

310

Citations

8

H-Index

YearCitations

Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver

Tao Zeng, Cuili Zhang, Ning Zhao,

Redox Biology

2017

109

S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways

Dan Fang, Chengfei Zhang, Ping Xu,

Cell Biology and Toxicology

2021

52

STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway

Chengfei Zhang, Xiaoming Wang, Dan Fang,

Theranostics

2020

42

KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma

Mo Xiao, Chengfei Zhang, Ping Xu,

Acta Pharmacologica Sinica

2021

39

Centromere protein F is identified as a novel therapeutic target by genomics profile and contributing to the progression of pancreatic cancer

Hongjin Chen, Xiaoming Wang, Fubing Wu,

Genomics

2020

23

KCNN4 promotes the progression of lung adenocarcinoma by activating the AKT and ERK signaling pathways

Ping Xu, Mo Xiao, Ruixue Xia,

Cancer Biomarkers

2021

17

Kupffer cells activation promoted binge drinking-induced fatty liver by activating lipolysis in white adipose tissues

Yuying Zhao, Rui Yang, Mo Xiao,

Toxicology

2017

16

Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma

Haojun Xu, Zhijie Ma, Mo Xiao,

Journal of Cancer

2022

12

Page 1